Position in PLRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$659,577
+$133,812 QoQ
Shares Held
578,577
+38.7% QoQ
Ownership
0.934%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 86 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PLRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,872,883,090 across 520 Biotechnology names. PLRX ranks #345 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in PLRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $659,577 | 578,577 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $525,765 | 417,274 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $723,088 | 592,696 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $869,364 | 587,409 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $675,799 | 582,586 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,826,607 | 1,353,043 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $17,340,253 | 1,316,648 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $14,778,232 | 1,318,308 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $13,836,184 | 1,287,087 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $18,101,756 | 1,214,883 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $21,500,155 | 1,187,198 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $19,528,550 | 1,126,214 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $17,911,112 | 988,472 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $11,443,825 | 430,219 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,757,922 | 349,608 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,849,162 | 327,868 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,770,073 | 220,983 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,844,763 | 405,815 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,395,869 | 399,694 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,409,263 | 320,454 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,207,646 | 281,856 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $11,096,251 | 282,132 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,380,758 | 148,801 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,059,380 | 135,072 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $600,282 | 18,493 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||